Ali H Alquraini (Ali Alquraini)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Bacillus Subtilis

Signaling Pathway

Top Venues

Sensors (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Afzal, Sami I Alzarea, Khalid Saad Alharbi, Abdulaziz I Alzarea, Sattam Khulaif Alenezi, Mohammed Salem Alshammari, Ali H Alquraini, Imran Kazmi
Rosiridin Attenuates Scopolamine-Induced Cognitive Impairments in Rats via Inhibition of Oxidative and Nitrative Stress Leaded Caspase-3/9 and TNF-α Signaling Pathways. Molecules (Basel, Switzerland) 27 (18) (2022)
Ameeduzzafar Zafar, Nabil K Alruwaili, Syed Sarim Imam, Omar Awad Alsaidan, Mohammed Muqtader Ahmed, Mohd Yasir, Musarrat Husain Warsi, Ali H Alquraini, Mohammed M Ghoneim, Sultan M Alshehri
Development and Optimization of Hybrid Polymeric Nanoparticles of Apigenin: Physicochemical Characterization, Antioxidant Activity and Cytotoxicity Evaluation. Sensors (Basel, Switzerland) 22 (4) (2022)
Ameeduzzafar Zafar, Nabil K Alruwaili, Syed Sarim Imam, Omar Awad Alsaidan, Faisal K Alkholifi, Khalid Saad Alharbi, Ehab M Mostafa, Abdullah Salah Alanazi, Sadaf Jamal Gilani, Arafa Musa, Sultan M Alshehri, Alenazy Rawaf, Ali H Alquraini
Formulation of Genistein-HP β Cyclodextrin-Poloxamer 188 Ternary Inclusion Complex: Solubility to Cytotoxicity Assessment. Pharmaceutics 13 (12) (2021)
Muhammad Afzal, Imran Kazmi, Fahad A Al-Abbasi, Sultan M Alshehri, Mohammed M Ghoneim, Syed Sarim Imam, Muhammad Shahid Nadeem, Maryam Hassan Al-Zahrani, Sami I Alzarea, Ali H Alquraini
Current Overview on Therapeutic Potential of Vitamin D in Inflammatory Lung Diseases. Biomedicines 9 (12) (2021)